Vaxcyte, Inc. - PCVX

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$6.613B
QoQ value delta ($000)
+$1.568B (+31.08%)
Implied price effect (QoQ)
+28.11%
Shares
Total shares
143,320,511
QoQ shares delta
+3,250,302 (+2.32%)
Total shares held by funds (by quarter)

Market chart (PCVX)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q1 2026 data: only 7 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
FMR LLC 638,324 13,834,514 0.03%
JANUS HENDERSON GROUP PLC 617,730 13,387,188 0.28%
VANGUARD GROUP INC 562,630 12,193,986 0.01%
T. Rowe Price Investment Management, Inc. 521,213 11,296,333 0.33%
RA CAPITAL MANAGEMENT, L.P. 494,832 10,724,599 5.07%
BlackRock, Inc. 472,767 10,246,378 0.01%
WELLINGTON MANAGEMENT GROUP LLP 275,285 5,966,310 0.05%
STATE STREET CORP 229,777 4,980,005 0.01%
Paradigm Biocapital Advisors LP 187,698 4,068,020 4.79%
Deep Track Capital, LP 184,560 4,000,000 3.29%
D. E. Shaw & Co., Inc. 167,536 3,631,053 0.09%
WESTFIELD CAPITAL MANAGEMENT CO LP 163,322 3,539,717 0.68%
Kynam Capital Management, LP 134,836 2,922,335 8.61%
GEODE CAPITAL MANAGEMENT, LLC 132,271 2,866,305 0.01%
ADAGE CAPITAL PARTNERS GP, L.L.C. 79,591 1,725,000 0.12%
Caligan Partners LP 78,660 1,704,815 6.48%
Polar Capital Holdings Plc 77,182 1,672,783 0.3%
Pivotal bioVenture Partners Investment Advisor LLC 63,323 1,372,425 24.48%
MAVERICK CAPITAL LTD 62,484 1,354,237 0.67%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 59,697 1,293,830 0.01%
NORGES BANK 56,703 1,228,939 0.01%
Eversept Partners, LP 55,262 1,197,722 2.78%
PRICE T ROWE ASSOCIATES INC /MD/ 54,232 1,175,339 0.01%
GOLDMAN SACHS GROUP INC 50,902 1,103,220 0.01%
UBS Group AG 50,458 1,093,593 0.01%